Abstract
Thein vitro potency of the immunosuppressants Cyclosporin A (CsA), FK-506 and Prednisolone was assessed using the adoptive transfer model of EAE in the Lewis rat. Co-culture of encephalitogen-sensitised splenic leukocytes with Prednisolone did not inhibit the transfer of disease to naive histocompatible recipients despite significant suppression of neuroantigen-stimulated leukocyte proliferation by the drug. The addition of CsA (100 nM) to cultures inhibited the induction of adoptive EAE but a lower dose of the agent (10 nM) did not prevent the development of clinico-histopathological signs of disease. FK-506 (1 nM) was 100 times more effective than CsA at suppressing adoptive EAE thus emphasising the usefulness of the model in determining the relative efficacy of compounds to modify cell-dependent autoimmune disease.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
P. Y. Paterson,Transfer of allergic encephalomyelitis in rats by means of lymph node cells. J. exp. Med.111, 119–135 (1960).
A. Ben-Nun, H. Wekerle and I. R. Cohen,The rapid isolation of clonable antigen-specific T lymphocyte lines capable of mediating autoimmune encephalomyelitis. Eur. J. Immunol.11, 195–199 (1981).
R. H. Swanborg,Autoimmune effector cells V: a monoclonal antibody specific for rat helper T lymphocytes inhibits adoptive transfer of autoimmune encephalomyelitis. J. Immunol.130, 1503–1505 (1983).
A. M. Carbone, H. Ovadia and P. Y. Paterson,Role of macrophage-myelin basic protein interaction in the induction of experimental allergic encephalomyelitis in Lewis rats. J. Immunol.131, 1263–1267 (1983).
H. S. Panitch and D. E. McFarlin,Experimental allergic encephalomyelitis: enhancement of cell-mediated transfer by concanavalin A. J. Immunol.119, 1134–1137 (1977).
J. R. Richert, B. F. Driscoll, M. Kies and E. C. Alvord,Adoptive transfer of experimentall allergic encepohalomyelitis: Incubation of rat spleen cells with specific antigen. J. Immunol.122, 494–496 (1979).
P. Y. Paterson,Autoimmune diseases of myelin. Prog. Clin. Biol. Res.49, 19–36 (1980).
B. G. W. Arnason,Relevance of experimental allergic encephalomyelitis to multiple slcerosis. Neurol. Clin.1, 765–782 (1983).
C. Bolton, G. Allsopp and M. L. Cuzner,The effect of cyclosporin A on the adoptive transfer of experimental allergic encephalomyelitis in the Lewis rat. Clin. exp. Immunol.47, 127–132 (1982).
M. E. Westarp, H. Wekerle, A. Ben-Nun, I. R. Cohen, M. L. Vohl and H. Przuntek,T lymphocyte line-mediated experimental allergic encephalomyelitis — a pharmacologic model for testing of immunosuppressive agents for the treatment of central nervous system disease. J. Pharmacol. Exp. Ther.242, 614–620 (1987).
S. Desai and R. Barton,Pharmacological comparison of active and passive experimental allergic encephalomyelitis in the rat. Ag. Act.27, 351–355 (1989).
C. Bolton, J. F. Borel, M. L. Cuzner, A. N. Davison and A. M. Turner,Autoimmunity: Cyclosporin A therapy in Experimental Allergic Encephalomyelitis. InCyclosporin A. (Ed. D. J. G. White) pp. 135–152, Oxford, UK, 1982.
P. Rudge, J. C. Koetsier, J. Mertin, J. O. Mispelblom Beyer, H. K. Van Walbeck, R. Clifford Jones, J. Harrison, K. Robinson, B. Mellein, T. Poole, J. C. J. M. Stokvis and P. Timonen,Randomised double blind controlled trial of cyclosporin in multiple sclerosis. J. Neurol. Neurosurg. Psych.52, 559–565 (1989).
N. Inamura, M. Hashimoto, K. Nakahara, Y. Nakajima, M. Nishio, H. Aoki, I. Yamaguchi and M. Kohsaka,Immunosuppressive effect of FK-506 on experimental allergic encephalomyelitis in rats. Int. J. Immunopharmacol.10, 991–995 (1988).
H. Kawashima, Y. Fujino and M. Mochizuki,Effects of a new immunosuppressive agent, FK-506, on experimental autoimmune uveoretinitis in rats. Invest. Opthalmol. Vis. Sci.29, 1265–1271 (1988).
N. Inamura, M. Hashimoto, K. Nakahara, H. Aoki, I. Yamaguchi and M. Kohsaka,Immunosuppressive effect of FK-506 on collagen-induced arthritis in rats. Clin. Immunol. Immunopathol.46, 82–90 (1988).
K. Takagishi, M. Yamamoto, A. Nishimura, G. Yamasaki, N. Kanazawa, T. Hotokebuchi and Kaibara,Effect of FK-506 on collagen arthritis in mice. Transplant Proc.21, 1056–1058 (1989).
K. Takabayashi, T. Koike, K. Kurasawa, R. Matsumura, T. Sato, H. Tomioka, I. Ito, T. Yoshiki and S. Yoshida,Effect of FK-506, a novel immunosuppressive drug on murine systemic lupus erythematosus. Clin. Immunol. Immunopathol.46, 82–90 (1989).
P. R. Dunkley and P. Carnegi,Isolation of myelin basic proteins. InResearch Methods in Neurochemistry Vol. 2, (Eds. N. M. and R. Rodnight) pp. 219–245, Plenum Press, N.Y. 1974.
S. Levine and R. Sowinski,Suppression of the hyperacute form of experimental allergic encephalomyelitis by drugs. Arch. Int. Pharmacodyn.230, 309–318 (1977).
S. L. Abreu,Interferon in experimental autoimmune encephalomyelitis (EAE): Effects of interferon on the antigen-enhanced adoptive transfer of EAE. Int. Archs. Allergy Appl. Immun.76, 302–307 (1985).
S. Sawada, G. Suzuki, Y. Kawase and F. Takaku,Novel immunosuppressive agent, FK-506. In vitro effects on the cloned T-cell activation. J. Immunol.139, 1797–1803 (1987).
J. Woo, M. Stephen and A. W. Thompson,Spleen lymphocyte populations and expression of activation markers in rats treated with the potent new immunosuppressive agent FK-506. Immunology65, 153–155 (1988).
J. E. Kay, S. E. Doe and C. R. Benzie,The mechanism of action of the immunosupressive drug FK-506. Cell. Immunol.124, 175–181 (1989).
T. Kino, H. Hatanaka, S. Miyata, N. Inamura, M. Nishiyama, T. Yajima, T. Goto, M. Okuhara, M. Kohsaka, H. Aoki and T. Ochiai,FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro. J. Antibiot. (Tokyo)40, 1256–1265 (1987).
M. J. Tocci, D. A. Matkovich, K. A. Collier, P. Kwot, F. Dumont, S. Lin, S. Degudicibus, J. J. Siekierka, J. Chin and N. I. Hutchinson,The immunosuppressant FK-506 selectively inhibits expression of early T cell activation genes. J. Immunol.143, 718–726 (1989).
F. J. Dumont, M. J. Stanch, S. L. Koprak, M. R. Melinon and N. H. Sigal,Distinct mechanisms of suppression of murine T cell activation by the related macrolides FK-506 and rapamycin. J. Immunol.144, 2151–258 (1990).
H. G. A. Bouwer, G. N. Dietsch and D. J. Hinrichs,Adoptive transfer of experimental allergic encephalomyelitis: conditions influencing memory and effector cell development. Cell Immunol.131, 219–231 (1990).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bolton, C. The efficacy of cyclosporin A, FK-506 and Prednisolone to modify the adoptive transfer of Experimental Allergic Encephalomyelitis (EAE). Agents and Actions 35, 79–84 (1992). https://doi.org/10.1007/BF01990955
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01990955